Regenerative Medicine Market to Hit $12.9 Billion
Regenerative medicine is developing an increasingly visible reputation in healthcare, both among patients and professionals. This innovative sector has enormous potential for changing outcomes for patients thanks to treatments such as cell-tissue therapeutics and products like exosomes and Chimeric antigen receptor T cell therapy. Patients are becoming increasingly aware of, not just the risks that are associated with regenerative medicine, but the advantages too. As a result, forecasts for the increase in the size of the regenerative medicine market are...
View full press release